Skip to main content

E-prescribing Market Size worth USD 4,017.79 Million by 2026, growing at a 5.5% CAGR; Major Incorporation by EHR Solutions to Propel Demand: Fortune Business Insights™

Written by Customer Service on . Posted in Mergers And Acquisitions.

Pune, June 19, 2020 (GLOBE NEWSWIRE) — The global e-prescribing market size is expected to touch USD 4,017.79 million by the end of 2026, attributable to the incorporation of e-prescribing software in the Electronic Health Record (EHR) solutions.  E-prescribing or electronic prescribing is a new technologic infrastructure that helps the medical professionals to write and send prescriptions directly to the pharmacy. Fortune Business Insights, in its recent report, titled, “E-prescribing Market Size, Share & Industry Analysis, By Delivery Mode (Web-based, On-premise), By Prescription Type (Controlled substance, Non controlled Substances) By End User (Hospitals, Physician’s offices, Pharmacies) and Regional Forecast, 2019-2026,” states that the value of the market was USD 863.64 million in 2018 and will exhibit a CAGR of 21.0% during 2019 to 2026.    What are the nature and future aspect of the e-prescribing market?Who are the shareholders of this market, and what are their growth strategies?Which segment will earn the highest share and why?The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.Please visit: https://www.fortunebusinessinsights.com/e-prescribing-market-102698
Cost-efficiency Features to Add Boost to MarketThe e-prescribing software program allows doctors to transmit a prescription to the pharmacies and healthcare clinics without losing any medical history of the patient. This, coupled with the associated benefits, such as quality medical care and improved safety of the patients, are the key factors promoting the electronic prescribing market growth. Additionally, they are convenient for both the physician and the patient. They are more cost-efficient, as compared to the traditional prescription methods. It would, thereby augment the growth of the market during the forecast period.On the flip side, implementing a new e-prescribing setup is expensive and requires high cost for maintenance, as well. This may hamper the market growth in the coming years. Nevertheless, the adoption of these therapeutic solutions in emerging economies is expected to create new opportunities for the market to flourish in the coming years. Nevertheless, the prevalence of various diseases requiring outpatient checkup services is likely to create lucrative growth opportunity in the near future.Segment:Web-based Segment will Attract Majority of Share Attributable to Online Implementation of SoftwareBased on segmentation by delivery mode type, the web-based mode type held the highest e-prescribing market share in 2018. This is because it is an online implementation of in-house servers that can be operated on the internet. It is nurtured by an organization for proper maintenance.Regional Analysis-
North America Gained Dominance Owing to Advent of Digitalization in Healthcare SectorRegion-wise, North America has a well-established healthcare infrastructure and is the first adopter of the latest technology in medical science. These factors are responsible for the growth of this region. In 2018, North America earned USD 399.61 million with the U.S. standing as a major contributor. A rise in the popularity of digitalization in the healthcare sector is likely to help this region continue its dominance in the market in the forecast period.On the other side, the market for e-prescribing in Asia Pacific will show significant growth opportunities from the rising number of players in this region and the development of better medical services in the emerging nations.Players Emphasizing on Organic and Inorganic Partnerships to Gain TractionThe global market for e-prescribing is dominated by Epic Systems Corporation owing to its specialization on interoperable technology and multiple secured contracts with small and large hospitals and healthcare centres. Some of the clients of this company include Johns Hopkins Health System, University of Utah Health Care, Vanderbilt Health System, Duke University Health System, UNC Health Care, and University of Utah Health Care. The other players are engaging in collaborative efforts such as mergers and acquisitions, joint ventures, and more to gain a significant position in the market.
Major Industry Developments of the Market Include:May 2016 – Sandwell & West Birmingham Hospitals NHS Trust and Cerner engaged in a joint venture for a big Electronic Patient Record (EPR) program. It offers bed management, clinical documentation, and critical care functionalities.December 2019 – An independent company dealing in integrated prescriptions and cost transparency solutions called RxRevu, declared a collaborative agreement with Cerner Corporation offering patient prescription pricing solutions for the EHR.
List of the Leading Companies in the E-prescribing Market Include:AthenahealthNextGen HealthcareEpic Systems CorporationPractice Fusion Inc.Practice Fusion, Inc.eClinical WorksMedical Information Technology, Inc. (MEDITECH)Cerner CorporationAllscripts Healthcare, LLCSurescriptsOther players
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/e-prescribing-market-102698

Detailed Table of Content:IntroductionResearch ScopeMarket SegmentationResearch MethodologyDefinitions and AssumptionsExecutive SummaryMarket DynamicsMarket DriversMarket RestraintsMarket OpportunitiesKey InsightsRecent Industry Developments Such as Mergers & AcquisitionsRegulatory Scenario for Key CountriesTechnological Advancements Pertaining to E-prescribing SolutionsData on EHR Adoption for Key CountriesKey Industry TrendsNew Product LaunchGlobal E- prescribing Market Analysis, Insights and Forecast, 2015-2026Key Findings / SummaryMarket Analysis, Insights and Forecast – By Delivery ModeWeb-basedOn-premiseMarket Analysis, Insights and Forecast – By Prescription TypeControlled substanceNon Controlled substanceMarket Analysis, Insights and Forecast – By End UserPhysician’s OfficeHospitalsPharmaciesMarket Analysis, Insights and Forecast – By RegionNorth AmericaEuropeAsia PacificLatin AmericaMiddle East & AfricaTOC Continued….!!!

Have a Look at Related Reports:Population Health Management Market Size, Share & Industry Analysis, By Component (Software, and Services), By Platform (Cloud-based, and On-premise), By End User (Healthcare Providers, Healthcare Payers, and Others), and Regional Forecast, 2019-2026Revenue Cycle Management Market Size, Share and Global Trend By Structure (In-house Outsource) By Function (Claims & Denial Management, Medical Coding & Billing, Clinical Documentation Improvement (CDI), Insurance, Others) By Type (Software, Services) and Geography Forecast till 2026mhealth Market Size, Share & Industry Analysis, By Category (By Apps {Disease & Treatment Management, Wellness Management}, By Wearable {Body & Temperature Monitors, Glucose Monitors}) By Services Type (Monitoring Services, Diagnostic Services, Treatment Services) By Service Provider (mhealth App Companies, Hospitals, Health Insurance) and Regional Forecast, 2019-2026
mhealth Apps Market Size, Share & Industry Analysis, By App Type (Disease & Treatment Management, Wellness Management, Others), By Application (Monitoring Services, Fitness Solutions, Diagnostic Services, Treatment Services, Others), By Operating System Type (Google Play Store, Apple App Store, Others) and Regional Forecast, 2019-2026
Clear Aligners Market Size, Share and Global Trend By Patient Age Group (Teenager, Adults), By End-User (Hospitals, Dental & Orthodontic Clinics) and Geography Forecast till 2026ePharmacy Market Size, Share and Global Trend By Product (Over-the-Counter Products, Prescription Medicine) and Geography forecast till 2026
About Us:Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.Contact Us:Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs
Press Release: https://www.fortunebusinessinsights.com/press-release/e-prescribing-market-9844

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.